DE60212086D1 - Stabile kristalle von pyrrolverbindungen - Google Patents

Stabile kristalle von pyrrolverbindungen

Info

Publication number
DE60212086D1
DE60212086D1 DE60212086T DE60212086T DE60212086D1 DE 60212086 D1 DE60212086 D1 DE 60212086D1 DE 60212086 T DE60212086 T DE 60212086T DE 60212086 T DE60212086 T DE 60212086T DE 60212086 D1 DE60212086 D1 DE 60212086D1
Authority
DE
Germany
Prior art keywords
degree
stable crystals
crystal
present
show
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60212086T
Other languages
English (en)
Other versions
DE60212086T2 (de
Inventor
Masami Tsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nippon Shinyaku Co Ltd
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of DE60212086D1 publication Critical patent/DE60212086D1/de
Publication of DE60212086T2 publication Critical patent/DE60212086T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE60212086T 2001-03-14 2002-03-13 Stabile kristalle von pyrrolverbindungen Expired - Fee Related DE60212086T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001072405 2001-03-14
JP2001072405 2001-03-14
PCT/JP2002/002331 WO2002072546A1 (fr) 2001-03-14 2002-03-13 Cristaux stables de compose de pyrrole

Publications (2)

Publication Number Publication Date
DE60212086D1 true DE60212086D1 (de) 2006-07-20
DE60212086T2 DE60212086T2 (de) 2007-01-04

Family

ID=18929993

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60212086T Expired - Fee Related DE60212086T2 (de) 2001-03-14 2002-03-13 Stabile kristalle von pyrrolverbindungen

Country Status (8)

Country Link
US (1) US7211678B2 (de)
EP (1) EP1369416B1 (de)
JP (1) JPWO2002072546A1 (de)
AT (1) ATE328869T1 (de)
DE (1) DE60212086T2 (de)
ES (1) ES2266451T3 (de)
TW (1) TWI239952B (de)
WO (1) WO2002072546A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9608502A (pt) 1995-06-07 1999-07-06 Nippon Shinyaku Co Ltd Derivado da pirrola e composição medicinal
AU1890299A (en) * 1998-01-14 1999-08-02 Nippon Shinyaku Co. Ltd. Potassium channel activators

Also Published As

Publication number Publication date
EP1369416A4 (de) 2005-02-09
EP1369416B1 (de) 2006-06-07
DE60212086T2 (de) 2007-01-04
US7211678B2 (en) 2007-05-01
JPWO2002072546A1 (ja) 2004-07-02
WO2002072546A1 (fr) 2002-09-19
ATE328869T1 (de) 2006-06-15
ES2266451T3 (es) 2007-03-01
EP1369416A1 (de) 2003-12-10
TWI239952B (en) 2005-09-21
US20050261161A1 (en) 2005-11-24

Similar Documents

Publication Publication Date Title
NO20032425D0 (no) Nye krystallformer av atorvastatin-hemi-kalsium og fremgangsmåter for deresfremstilling, samt nye fremgangsmåter for fremstilling av andreformer
ATE215954T1 (de) Pyrazolo(4,3-d)pyrimidin-derivate und diese enthaltende pharmazeutische zubereitungen
CY1106969T1 (el) Αναστολεις dpp-iv
CY1110565T1 (el) Μεθοδος για την προστασια υλικων
IL159418A0 (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
ATE162521T1 (de) 3-aminopiperidine derivate und verwandete stickstoff enthaltende heterocyclische verbindungen
CY1105674T1 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
DE59310146D1 (de) Sulfonamidocarbonylpyridin-2-carbonsäureamide und ihre Verwendung als Arzneimittel
ATE354622T1 (de) Flüssigkristallines medium
DE69516186D1 (de) Verwendung von Beta-Aminopropionsäure-Derivaten als Fungizide
BR0114812A (pt) Derivados de 2-pirimidinilóxi-n-aril-benzilamina, seus processos de preparo e uso
DE60212086D1 (de) Stabile kristalle von pyrrolverbindungen
DE69331003D1 (de) Kristalle von derivaten von chinozon carbonsäure-hydraten
GB9411828D0 (en) Synthesis of substituted triphenylenes, useful as discotic liquid crystals
PT1277750E (pt) Hidratos e cristais de um composto de acido neuraminico
HK1064673A1 (en) Fused-polycyclic compounds
DK1295870T3 (da) Suplatasttosilatkrystaller
ATE170862T1 (de) 5-ht3 pyrrolopyrazinderivate
ATE334977T1 (de) Discodermolid-analoga und ihre pharmazeutische verwendung
WO2000043375A3 (de) Substituierte arylheterocyclen
AU2002349487A1 (en) Substituted 6-membered n-heterocyclic compounds and their uses as neurological regulator
DE50210727D1 (de) Verwendung von arzneimitteln enthaltend n, n'-disubstituierte piperazin-verbindungen
FI960588A0 (fi) Mikrobisideina käytettäviä tiokarbamoyyliyhdisteitä
DK1499312T3 (da) Anvendelse af hydroxypyridonderivater til sårheling
WO2005026105A3 (en) Process for the synthesis of 3-(3-fluoro-4-hydroxyphenyl)-7-hydroxynaphthonitrile

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee